Merck to buy Imago BioSciences for $1.35 billion

Imago is developing new medicines for the treatment of myeloproliferative neoplasms and other bone marrow diseases.

Source: bizjournals.com Health Care:Pharmaceuticals headlines - November 21, 2022 Category: Pharmaceuticals Authors: I-Chun Chen Source Type: news